Cisplatin (cisplatin): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

Cisplatin 1 mg/ml Concentrate for Solution for Infusion

Cisplatin is intended for the treatment of:

• advanced or metastasised testicular cancer

• advanced or metastasised ovarian cancer

• advanced or metastasised bladder carcinoma

• advanced or metastasised squamous cell carcinoma of the head and neck

• advanced or metastasised non-small cell lung carcinoma

• advanced or metastasised small cell lung carcinoma.

Cisplatin is indicated in the treatment of cervical carcinoma in combination with other chemotherapeutics or with radiotherapy.

Cisplatin can be used as monotherapy and in combination therapy

Cisplatin 1 mg/ml Sterile Concentrate

Cisplatin is intended for the treatment of:

- Advanced or metastasised testicular cancer

- Advanced or metastasised ovarian cancer

- Advanced or metastasised bladder carcinoma

- Advanced or metastasised squamous cell carcinoma of the head and neck

- Advanced or metastasised non-small cell lung carcinoma

- Advanced or metastasised small cell lung carcinoma

Cisplatin is indicated in the treatment of cervical carcinoma in combination with other chemotherapeutics or with radiotherapy.

Cisplatin can be used as monotherapy and in combination therapy.

Cisplatin 1mg/ml Injection BP

To be used as mono-therapy, or as part of an existing chemotherapy for advanced or metastatic tumours: testicular carcinoma (palliative and curative poly-chemotherapy) and ovary carcinoma (stages III and IV), and head and neck squamous-cell epithelioma (palliative therapy).

In the treatment of small cell lung carcinoma.

In the treatment of advanced non-small cell lung carcinoma.


Route of administration: Injectable
Molecule: cisplatin

Patients' opinions on Cisplatin

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.